CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 200 of 219 entries

View as:

Eptinezumab in Adults With Migraine and Medication Overuse Headache

Phase: N/A Priority: Normal

NCT ID: NCT04772742 Org: User:

Start: 02/17/21 End: 09/30/22 Due: 09/30/23

Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)

Phase: N/A Priority: Normal

NCT ID: NCT00266357 Org: User:

Start: 11/30/05 End: - Due: -

A Study to Evaluate Lu AF90103 in Healthy Men

Phase: N/A Priority: Normal

NCT ID: NCT04940949 Org: User:

Start: 05/26/21 End: 11/23/21 Due: 11/23/22

Pharmacokinetic Properties of Lu AA21004 (Vortioxetine) in Healthy Young Chinese Men and Women

Phase: N/A Priority: Normal

NCT ID: NCT01676571 Org: User:

Start: 10/31/12 End: - Due: -

Exploratory Cognition Study of Sertindole in Patients With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00759421 Org: User:

Start: 10/31/06 End: 04/30/08 Due: 04/30/09

Eptinezumab in Healthy Japanese Subjects

Phase: N/A Priority: Normal

NCT ID: NCT04336449 Org: User:

Start: 04/01/20 End: 08/13/20 Due: 08/13/21

Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Phase: N/A Priority: Normal

NCT ID: NCT01838681 Org: User:

Start: 06/30/13 End: 06/30/16 Due: 06/30/17

Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)

Phase: N/A Priority: Normal

NCT ID: NCT00102167 Org: User:

Start: 02/28/05 End: 12/31/05 Due: 12/31/06

Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder

Phase: N/A Priority: Normal

NCT ID: NCT02901587 Org: User:

Start: 09/30/16 End: 04/18/18 Due: 04/18/19

Aripiprazole Once-monthly in Patients With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT01959035 Org: User:

Start: 10/31/13 End: 03/31/15 Due: 03/31/16

What the Body Does to Foliglurax in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT04002895 Org: User:

Start: 06/27/19 End: 08/08/19 Due: 08/08/20

A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)

Phase: N/A Priority: Normal

NCT ID: NCT05064397 Org: User:

Start: 09/17/21 End: 06/29/23 Due: 06/29/24

A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy

Phase: N/A Priority: Normal

NCT ID: NCT05081518 Org: User:

Start: 09/29/21 End: 04/14/22 Due: 04/14/23

Safety and Tolerability of Lu AG06479 in Healthy Young Men

Phase: N/A Priority: Normal

NCT ID: NCT04473651 Org: User:

Start: 07/09/20 End: 11/10/21 Due: 11/10/22

Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00763438 Org: User:

Start: 11/30/07 End: 10/31/10 Due: 10/31/11

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal

NCT ID: NCT02709746 Org: User:

Start: 05/31/16 End: 07/30/19 Due: 07/30/20

Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00810667 Org: User:

Start: 11/30/08 End: 02/28/10 Due: 02/28/11

Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder

Phase: N/A Priority: Normal

NCT ID: NCT02279966 Org: User:

Start: 10/31/14 End: 02/29/16 Due: 02/28/17

Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

Phase: N/A Priority: Normal

NCT ID: NCT00095069 Org: User:

Start: 10/31/04 End: 02/28/07 Due: 02/28/08

A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants

Phase: N/A Priority: Normal

NCT ID: NCT05320302 Org: User:

Start: 03/31/22 End: 06/20/22 Due: 06/20/23

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00807248 Org: User:

Start: 11/30/08 End: 02/28/10 Due: 02/28/11

A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease

Phase: N/A Priority: Normal

NCT ID: NCT06557850 Org: User:

Start: 09/19/24 End: 09/29/26 Due: 09/29/27

Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke

Phase: N/A Priority: Normal

NCT ID: NCT00870844 Org: User:

Start: 05/31/09 End: 03/31/11 Due: 03/31/12

A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab

Phase: N/A Priority: Normal

NCT ID: NCT04537429 Org: User:

Start: 08/04/20 End: 08/21/23 Due: 08/21/24

A Study of Lu AF82422 in Participants With Multiple System Atrophy

Phase: N/A Priority: Normal

NCT ID: NCT05104476 Org: User:

Start: 11/16/21 End: 05/14/26 Due: 05/14/27

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Eptinezumab in Adults With Migraine and Medication Overuse Headache	NCT04772742	H. Lundbeck A/S	user2@example.com	None	2021-02-17	2022-09-30	2023-09-30	-	-	2025-07-14
Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)	NCT00266357	H. Lundbeck A/S	user2@example.com	None	2005-11-30	-	-	-	-	2025-07-14
A Study to Evaluate Lu AF90103 in Healthy Men	NCT04940949	H. Lundbeck A/S	user2@example.com	None	2021-05-26	2021-11-23	2022-11-23	-	-	2025-07-14
Pharmacokinetic Properties of Lu AA21004 (Vortioxetine) in Healthy Young Chinese Men and Women	NCT01676571	H. Lundbeck A/S	user2@example.com	None	2012-10-31	-	-	-	-	2025-07-14
Exploratory Cognition Study of Sertindole in Patients With Schizophrenia	NCT00759421	H. Lundbeck A/S	user2@example.com	None	2006-10-31	2008-04-30	2009-04-30	-	-	2025-07-14
Eptinezumab in Healthy Japanese Subjects	NCT04336449	H. Lundbeck A/S	user2@example.com	None	2020-04-01	2020-08-13	2021-08-13	-	-	2025-07-14
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment	NCT01838681	H. Lundbeck A/S	user2@example.com	None	2013-06-30	2016-06-30	2017-06-30	-	-	2025-07-14
Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)	NCT00102167	H. Lundbeck A/S	user2@example.com	None	2005-02-28	2005-12-31	2006-12-31	-	-	2025-07-14
Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder	NCT02901587	H. Lundbeck A/S	user2@example.com	None	2016-09-30	2018-04-18	2019-04-18	-	-	2025-07-14
Aripiprazole Once-monthly in Patients With Schizophrenia	NCT01959035	H. Lundbeck A/S	user2@example.com	None	2013-10-31	2015-03-31	2016-03-31	-	-	2025-07-14
What the Body Does to Foliglurax in Healthy Volunteers	NCT04002895	H. Lundbeck A/S	user2@example.com	None	2019-06-27	2019-08-08	2020-08-08	-	-	2025-07-14
A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)	NCT05064397	H. Lundbeck A/S	user2@example.com	None	2021-09-17	2023-06-29	2024-06-29	-	-	2025-07-14
A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy	NCT05081518	H. Lundbeck A/S	user2@example.com	None	2021-09-29	2022-04-14	2023-04-14	-	-	2025-07-14
Safety and Tolerability of Lu AG06479 in Healthy Young Men	NCT04473651	H. Lundbeck A/S	user2@example.com	None	2020-07-09	2021-11-10	2022-11-10	-	-	2025-07-14
Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia	NCT00763438	H. Lundbeck A/S	user2@example.com	None	2007-11-30	2010-10-31	2011-10-31	-	-	2025-07-14
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)	NCT02709746	H. Lundbeck A/S	user2@example.com	None	2016-05-31	2019-07-30	2020-07-30	-	-	2025-07-14
Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia	NCT00810667	H. Lundbeck A/S	user2@example.com	None	2008-11-30	2010-02-28	2011-02-28	-	-	2025-07-14
Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder	NCT02279966	H. Lundbeck A/S	user2@example.com	None	2014-10-31	2016-02-29	2017-02-28	-	-	2025-07-14
Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)	NCT00095069	H. Lundbeck A/S	user2@example.com	None	2004-10-31	2007-02-28	2008-02-28	-	-	2025-07-14
A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants	NCT05320302	H. Lundbeck A/S	user2@example.com	None	2022-03-31	2022-06-20	2023-06-20	-	-	2025-07-14
Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder	NCT00807248	H. Lundbeck A/S	user2@example.com	None	2008-11-30	2010-02-28	2011-02-28	-	-	2025-07-14
A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease	NCT06557850	H. Lundbeck A/S	user2@example.com	None	2024-09-19	2026-09-29	2027-09-29	-	-	2025-07-14
Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke	NCT00870844	H. Lundbeck A/S	user2@example.com	None	2009-05-31	2011-03-31	2012-03-31	-	-	2025-07-14
A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab	NCT04537429	H. Lundbeck A/S	user2@example.com	None	2020-08-04	2023-08-21	2024-08-21	-	-	2025-07-14
A Study of Lu AF82422 in Participants With Multiple System Atrophy	NCT05104476	H. Lundbeck A/S	user2@example.com	None	2021-11-16	2026-05-14	2027-05-14	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance